Quality-of-Life Comparison of Dapagliflozin Versus Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (J-BOND Study)

INTRODUCTION: No study has compared the effects of sodium–glucose cotransporter 2 inhibitors (SGLT2is) and dipeptidyl peptidase 4 inhibitors (DPP4is) on patients’ quality-of-life (QOL). METHODS: We enrolled 253 drug-naïve Japanese patients with type 2 diabetes mellitus (T2DM), randomly assigned them...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Hitoshi, Nakajima, Hiroki, Kamei, Nozomu, Niiya, Tetsuji, Hiyoshi, Toru, Hiramori, Yuko, Ohtsu, Shigeyuki, Noto, Takashi, Shimono, Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644655/
https://www.ncbi.nlm.nih.gov/pubmed/33057967
http://dx.doi.org/10.1007/s13300-020-00941-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644655/
https://www.ncbi.nlm.nih.gov/pubmed/33057967
http://dx.doi.org/10.1007/s13300-020-00941-8

Ejemplares similares